nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—DRD1—G alpha (s) signalling events—SCT—duodenum cancer	0.0228	0.0228	CbGpPWpGaD
Paliperidone—HTR2C—G alpha (q) signalling events—GAST—duodenum cancer	0.0148	0.0148	CbGpPWpGaD
Paliperidone—ADRA1B—G alpha (q) signalling events—GAST—duodenum cancer	0.0142	0.0142	CbGpPWpGaD
Paliperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0133	0.0133	CbGpPWpGaD
Paliperidone—HTR2A—G alpha (q) signalling events—GAST—duodenum cancer	0.0129	0.0129	CbGpPWpGaD
Paliperidone—HRH1—G alpha (q) signalling events—GAST—duodenum cancer	0.0128	0.0128	CbGpPWpGaD
Paliperidone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0127	0.0127	CbGpPWpGaD
Paliperidone—ADRA1A—G alpha (q) signalling events—GAST—duodenum cancer	0.0126	0.0126	CbGpPWpGaD
Paliperidone—HTR1A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.0118	0.0118	CbGpPWpGaD
Paliperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0115	0.0115	CbGpPWpGaD
Paliperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0115	0.0115	CbGpPWpGaD
Paliperidone—HTR1D—G alpha (i) signalling events—SST—duodenum cancer	0.0114	0.0114	CbGpPWpGaD
Paliperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0113	0.0113	CbGpPWpGaD
Paliperidone—HTR1B—G alpha (i) signalling events—SST—duodenum cancer	0.0112	0.0112	CbGpPWpGaD
Paliperidone—DRD4—G alpha (i) signalling events—SST—duodenum cancer	0.011	0.011	CbGpPWpGaD
Paliperidone—HTR2A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.0102	0.0102	CbGpPWpGaD
Paliperidone—DRD3—G alpha (i) signalling events—SST—duodenum cancer	0.00975	0.00975	CbGpPWpGaD
Paliperidone—HTR1D—GPCR ligand binding—SCT—duodenum cancer	0.00954	0.00954	CbGpPWpGaD
Paliperidone—HTR1B—GPCR ligand binding—SCT—duodenum cancer	0.00935	0.00935	CbGpPWpGaD
Paliperidone—DRD4—GPCR ligand binding—SCT—duodenum cancer	0.0092	0.0092	CbGpPWpGaD
Paliperidone—HTR1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00906	0.00906	CbGpPWpGaD
Paliperidone—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00887	0.00887	CbGpPWpGaD
Paliperidone—ADRA2B—G alpha (i) signalling events—SST—duodenum cancer	0.00881	0.00881	CbGpPWpGaD
Paliperidone—DRD4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00873	0.00873	CbGpPWpGaD
Paliperidone—HTR1A—G alpha (i) signalling events—SST—duodenum cancer	0.0085	0.0085	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—SCT—duodenum cancer	0.00828	0.00828	CbGpPWpGaD
Paliperidone—ADRA2C—G alpha (i) signalling events—SST—duodenum cancer	0.00823	0.00823	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—SCT—duodenum cancer	0.00817	0.00817	CbGpPWpGaD
Paliperidone—DRD1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00786	0.00786	CbGpPWpGaD
Paliperidone—DRD3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00776	0.00776	CbGpPWpGaD
Paliperidone—DRD2—G alpha (i) signalling events—SST—duodenum cancer	0.00746	0.00746	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—SCT—duodenum cancer	0.00738	0.00738	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—SCT—duodenum cancer	0.00712	0.00712	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.00708	0.00708	CbGpPWpGaD
Paliperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.007	0.007	CbGpPWpGaD
Paliperidone—HTR1D—GPCR ligand binding—SST—duodenum cancer	0.0069	0.0069	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—SCT—duodenum cancer	0.00689	0.00689	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—SCT—duodenum cancer	0.00678	0.00678	CbGpPWpGaD
Paliperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00676	0.00676	CbGpPWpGaD
Paliperidone—HTR1B—GPCR ligand binding—SST—duodenum cancer	0.00676	0.00676	CbGpPWpGaD
Paliperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00672	0.00672	CbGpPWpGaD
Paliperidone—ADRA2A—G alpha (i) signalling events—SST—duodenum cancer	0.00668	0.00668	CbGpPWpGaD
Paliperidone—DRD4—GPCR ligand binding—SST—duodenum cancer	0.00665	0.00665	CbGpPWpGaD
Paliperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00654	0.00654	CbGpPWpGaD
Paliperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00644	0.00644	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—SCT—duodenum cancer	0.00625	0.00625	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00615	0.00615	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—SCT—duodenum cancer	0.00614	0.00614	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—SCT—duodenum cancer	0.00602	0.00602	CbGpPWpGaD
Paliperidone—DRD1—GPCR ligand binding—SST—duodenum cancer	0.00599	0.00599	CbGpPWpGaD
Paliperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00593	0.00593	CbGpPWpGaD
Paliperidone—DRD3—GPCR ligand binding—SST—duodenum cancer	0.00591	0.00591	CbGpPWpGaD
Paliperidone—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00584	0.00584	CbGpPWpGaD
Paliperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00583	0.00583	CbGpPWpGaD
Paliperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00572	0.00572	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—GAST—duodenum cancer	0.00569	0.00569	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—SCT—duodenum cancer	0.0056	0.0056	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—GAST—duodenum cancer	0.00557	0.00557	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—GAST—duodenum cancer	0.00548	0.00548	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—SCT—duodenum cancer	0.00539	0.00539	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR ligand binding—SST—duodenum cancer	0.00533	0.00533	CbGpPWpGaD
Paliperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00531	0.00531	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—SCT—duodenum cancer	0.00528	0.00528	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—SCT—duodenum cancer	0.0052	0.0052	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—GAST—duodenum cancer	0.00517	0.00517	CbGpPWpGaD
Paliperidone—HTR1A—GPCR ligand binding—SST—duodenum cancer	0.00515	0.00515	CbGpPWpGaD
Paliperidone—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.00512	0.00512	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—GAST—duodenum cancer	0.00506	0.00506	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR ligand binding—SST—duodenum cancer	0.00498	0.00498	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—GAST—duodenum cancer	0.00498	0.00498	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—GAST—duodenum cancer	0.00494	0.00494	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR ligand binding—SST—duodenum cancer	0.0049	0.0049	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—SCT—duodenum cancer	0.0049	0.0049	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—GAST—duodenum cancer	0.00487	0.00487	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—SCT—duodenum cancer	0.0048	0.0048	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—SCT—duodenum cancer	0.00472	0.00472	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—SCT—duodenum cancer	0.00468	0.00468	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—SCT—duodenum cancer	0.00462	0.00462	CbGpPWpGaD
Paliperidone—DRD2—GPCR ligand binding—SST—duodenum cancer	0.00452	0.00452	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—GAST—duodenum cancer	0.00448	0.00448	CbGpPWpGaD
Paliperidone—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00445	0.00445	CbGpPWpGaD
Paliperidone—HRH1—GPCR ligand binding—SST—duodenum cancer	0.00444	0.00444	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—GAST—duodenum cancer	0.00442	0.00442	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—GAST—duodenum cancer	0.0044	0.0044	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR ligand binding—SST—duodenum cancer	0.00435	0.00435	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—SCT—duodenum cancer	0.00425	0.00425	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—GAST—duodenum cancer	0.00424	0.00424	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.00422	0.00422	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—SCT—duodenum cancer	0.00419	0.00419	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—SCT—duodenum cancer	0.00417	0.00417	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—GAST—duodenum cancer	0.00411	0.00411	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR ligand binding—SST—duodenum cancer	0.00405	0.00405	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—GAST—duodenum cancer	0.00404	0.00404	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—SCT—duodenum cancer	0.00402	0.00402	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.004	0.004	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—GAST—duodenum cancer	0.00399	0.00399	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—SST—duodenum cancer	0.0039	0.0039	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—SCT—duodenum cancer	0.00389	0.00389	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—GAST—duodenum cancer	0.00385	0.00385	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—SCT—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—SST—duodenum cancer	0.00382	0.00382	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—SCT—duodenum cancer	0.00378	0.00378	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—SST—duodenum cancer	0.00376	0.00376	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—GAST—duodenum cancer	0.00373	0.00373	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—GAST—duodenum cancer	0.00373	0.00373	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—GAST—duodenum cancer	0.00367	0.00367	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00367	0.00367	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—GAST—duodenum cancer	0.00366	0.00366	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—SCT—duodenum cancer	0.00365	0.00365	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.00363	0.00363	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—GAST—duodenum cancer	0.00359	0.00359	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—SST—duodenum cancer	0.00354	0.00354	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—SCT—duodenum cancer	0.00354	0.00354	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—SCT—duodenum cancer	0.00353	0.00353	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—SCT—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—SCT—duodenum cancer	0.00347	0.00347	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—SST—duodenum cancer	0.00347	0.00347	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—SST—duodenum cancer	0.00341	0.00341	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—SCT—duodenum cancer	0.0034	0.0034	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—GAST—duodenum cancer	0.00338	0.00338	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—SST—duodenum cancer	0.00338	0.00338	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—SST—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—GAST—duodenum cancer	0.00334	0.00334	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00333	0.00333	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—GAST—duodenum cancer	0.00332	0.00332	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—GAST—duodenum cancer	0.00326	0.00326	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—SCT—duodenum cancer	0.00321	0.00321	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—SCT—duodenum cancer	0.00316	0.00316	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.00316	0.00316	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—SCT—duodenum cancer	0.00315	0.00315	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—SCT—duodenum cancer	0.00309	0.00309	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—SST—duodenum cancer	0.00307	0.00307	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—GAST—duodenum cancer	0.00305	0.00305	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—SST—duodenum cancer	0.00303	0.00303	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—GAST—duodenum cancer	0.00303	0.00303	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—SST—duodenum cancer	0.00301	0.00301	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—GAST—duodenum cancer	0.00299	0.00299	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—GAST—duodenum cancer	0.00294	0.00294	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—SST—duodenum cancer	0.00291	0.00291	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.00289	0.00289	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SCT—duodenum cancer	0.00289	0.00289	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—SCT—duodenum cancer	0.00287	0.00287	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SCT—duodenum cancer	0.00283	0.00283	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—SST—duodenum cancer	0.00281	0.00281	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SCT—duodenum cancer	0.00279	0.00279	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—SST—duodenum cancer	0.00277	0.00277	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—SST—duodenum cancer	0.00274	0.00274	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—GAST—duodenum cancer	0.00265	0.00265	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—SST—duodenum cancer	0.00264	0.00264	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.00263	0.00263	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—GAST—duodenum cancer	0.00261	0.00261	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—SST—duodenum cancer	0.00256	0.00256	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—SST—duodenum cancer	0.00255	0.00255	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MEN1—duodenum cancer	0.00253	0.00253	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—SST—duodenum cancer	0.00252	0.00252	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.00251	0.00251	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SCT—duodenum cancer	0.00251	0.00251	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—SST—duodenum cancer	0.00251	0.00251	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MEN1—duodenum cancer	0.00248	0.00248	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SCT—duodenum cancer	0.00248	0.00248	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—SST—duodenum cancer	0.00246	0.00246	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MEN1—duodenum cancer	0.00244	0.00244	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—GAST—duodenum cancer	0.00236	0.00236	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—SST—duodenum cancer	0.00232	0.00232	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—SST—duodenum cancer	0.00229	0.00229	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00228	0.00228	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—SST—duodenum cancer	0.00228	0.00228	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—GAST—duodenum cancer	0.00228	0.00228	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00227	0.00227	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SCT—duodenum cancer	0.00224	0.00224	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—SST—duodenum cancer	0.00223	0.00223	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—GAST—duodenum cancer	0.0022	0.0022	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MEN1—duodenum cancer	0.00219	0.00219	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—GAST—duodenum cancer	0.00217	0.00217	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MEN1—duodenum cancer	0.00216	0.00216	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SCT—duodenum cancer	0.00216	0.00216	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00215	0.00215	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—SST—duodenum cancer	0.00209	0.00209	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SCT—duodenum cancer	0.00209	0.00209	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—SST—duodenum cancer	0.00208	0.00208	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SCT—duodenum cancer	0.00206	0.00206	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—SST—duodenum cancer	0.00205	0.00205	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—SST—duodenum cancer	0.00202	0.00202	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—GAST—duodenum cancer	0.002	0.002	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.00197	0.00197	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—GAST—duodenum cancer	0.00196	0.00196	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MEN1—duodenum cancer	0.00195	0.00195	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—GAST—duodenum cancer	0.00193	0.00193	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SCT—duodenum cancer	0.0019	0.0019	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MEN1—duodenum cancer	0.00189	0.00189	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.00188	0.00188	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00186	0.00186	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SCT—duodenum cancer	0.00186	0.00186	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SCT—duodenum cancer	0.00183	0.00183	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MEN1—duodenum cancer	0.00183	0.00183	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—SST—duodenum cancer	0.00181	0.00181	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MEN1—duodenum cancer	0.0018	0.0018	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—SST—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GAST—duodenum cancer	0.00179	0.00179	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SCT—duodenum cancer	0.0017	0.0017	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MEN1—duodenum cancer	0.00166	0.00166	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.00163	0.00163	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MEN1—duodenum cancer	0.00163	0.00163	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—SST—duodenum cancer	0.00162	0.00162	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MEN1—duodenum cancer	0.0016	0.0016	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—SST—duodenum cancer	0.00156	0.00156	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—SST—duodenum cancer	0.00155	0.00155	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—SST—duodenum cancer	0.00151	0.00151	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—SST—duodenum cancer	0.00149	0.00149	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MEN1—duodenum cancer	0.00148	0.00148	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—SST—duodenum cancer	0.00137	0.00137	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—SST—duodenum cancer	0.00135	0.00135	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—SST—duodenum cancer	0.00135	0.00135	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SST—duodenum cancer	0.00132	0.00132	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SST—duodenum cancer	0.00123	0.00123	CbGpPWpGaD
